Gloucestershire Hospitals NHS Foundation Trust selects Allscripts Sunrise™ to Continue its Digital Journey

AllscriptsGloucestershire Hospitals NHS Foundation Trust has selected Allscripts (NASDAQ: MDRX) Sunrise™ as its electronic health record (EHR), in a move that will help the Trust further strengthen its patient centric digital strategy and solidifies the company's position in the South West of England.

The Trust has 8,000 staff members, 960 beds and provides a wide range of specialist hospital services from its two main sites at Gloucestershire Royal and Cheltenham General Hospitals, as well as maternity services at Stroud Maternity Hospital.

Working with GHFT and other suppliers, Allscripts will collaborate to deliver digital solutions that enable improvements in patient care and enhance clinical outcomes for the Gloucestershire community.

"We believe Sunrise is the right EPR solution to support the Trust to deliver agile digital maturity and deliver outstanding staff and patient experience," said Deborah Lee, Chief Executive Officer at Gloucestershire Hospitals NHS Foundation Trust. "Along with improvements in patient outcomes and operational performance, we're confident that our investment in the Allscripts solution, a clinical wrap around our Patient Administration System, will improve the Trust’s digital maturity supporting the Trusts strategy and ambitions."

Used by healthcare organizations across the globe, Allscripts Sunrise is an integrated electronic health record that connects all aspects of care, including ambulatory, surgical, radiology and laboratory services. Built to enable efficient and safe care, Sunrise is a clinician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalized medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience for the consumer.

"Implementing EPRs that are open and interoperable is critical to efficient sharing of information between the area's main Trusts and the surrounding community," said Richard Strong, Allscripts U.K. Managing Director. "Gloucestershire Hospitals NHS Foundation Trust’s decision to select the Sunrise solution will position the Trust to communicate effectively, improve patient and health outcomes and drive efficiencies."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...